GlassScriptPhysician profile
Felix C Blanco
NPI 1225385891
$3,274.01
in general payments reported to CMS, 2019-2025
11 companies · $1,898 in 2025
The $1,898 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2021: $107 · 2023: $87.24 · 2024: $86.79 · 2025: $1,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,517 · Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,516.94 |
| Food and Beverage | $555.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,516.94 | 2025 | |
| Medical Device Business Services, INC. | $882.63 | 2019 | |
| Enterra Medical, INC. | $381.26 | 2025 | |
| Smith+Nephew, INC. | $186.83 | 2019-2023 | Grafix Pl |
| Ethicon US, LLC | $130.23 | 2019 | |
| Abbott Laboratories | $71.34 | 2024 | Assurity |
| Organogenesis INC. | $33.96 | 2023 | Puraply |
| Osiris Therapeutics INC. | $20.77 | 2019 | |
| Endogastric Solutions, INC | $19.43 | 2023 | Esophyx |
| Kerecis Limited | $15.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Microline Surgical INC | $15.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.